Identification of a Small Molecule Compound Active against Antibiotic-Tolerant Staphylococcus aureus by Boosting ATP...

Area of Science:

• Microbiology
• Infectious Diseases
• Drug Discovery

Background:

• Antibiotic tolerance in bacteria leads to persistent infections, treatment failure, and increased healthcare burdens.
• Developing strategies against antibiotic-tolerant bacteria is crucial for combating challenging infections.

Purpose of the Study:

• To identify and characterize novel compounds effective against antibiotic-tolerant Staphylococcus aureus.
• To investigate the mechanism of action of SA-558 and its efficacy in preclinical models.

Main Methods:

• Screening of small molecule compounds to identify activity against tolerant bacteria.
• Investigating the effects of SA-558 on bacterial membrane transport, ATP, and reactive oxygen species (ROS) generation.
• Evaluating SA-558 efficacy alone and in combination with vancomycin in a murine chronic infection model.

Main Results:

• SA-558 was identified as effective against antibiotic-tolerant Staphylococcus aureus.
• SA-558 promotes electroneutral transport, increases intracellular ATP and ROS, and reduces tolerant bacterial populations.
• SA-558, both as monotherapy and in combination with vancomycin, significantly reduced MRSA burden in a murine model where vancomycin alone failed.

Conclusions:

• SA-558 represents a promising therapeutic candidate for managing persistent Staphylococcus aureus infections.
• Targeting bacterial metabolism is a viable strategy to overcome antibiotic tolerance.
• SA-558 offers a potential new approach for treating infections caused by antibiotic-tolerant bacteria.